Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories
French President Emmanuel Macron was reportedly “angry” when he heard that the French pharmaceutical was considering making the U.S. market a priority for the manufacturing and distribution of its eventual coronavirus vaccine.